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Abstract
This paper analyses the goals and focuses of agricultural biotechnolo-
gy as well as the attitudes toward food safety in the North (advanced
countries) and the South (developing countries) amid the rapid adop-
tion and commercialization of biotech foods worldwide. In advanced
countries like the US, EU nations and Japan, the agricultural
biotechnology industry is well-organized with advanced and cutting
edge technology and they have strong national agricultural research sys-
tems and well-placed regulatory frameworks. Here too the consumers
are very knowledgeable, sophisticated and demanding so there is pres-
sure for all supply chain agents to provide them with safe food. In de-
veloping countries of Asia for example, on the other hand, the agricul-
tural biotech industry is still in the infant stage where much of the R&D
are done by public institutions to address more pressing needs such as
poverty, malnutrition and food security. Price is still a determining fac-
tor in the purchase decisions of consumers and the food supply chain
and the regulatory framework in developing countries are still weak. In
harmony with the international and regional agreements on food safety,
proactively, it is important for developing countries in Asia that are
rapidly growing and preparing to commercialize biotech foods (e.g.
GMOs). to have in place measures so that food safety is assured
throughout the supply chain.
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Introduction
Issues about food, especially products of biotechnology and food safety have
received a lot of attention recently. They deal with the food we and our chil-
dren eat hence there are a lot of emotions attached to the challenging, com-
plex and wide-range issues about biotechnology and biotech foods (e.g.
GMOs) based on health and environmental grounds. These are controversial
issues across the world that keep the global community divided. With the
globalization of the world economy and as more countries become more in-
terdependent, international trade in biotech food is also expected to grow
from now on.
The products of the "Gene revolution" have received much praise and criti-
cisms worldwide as more countries are preparing to commercialize GMO
"food. The gene revolution has evolved from the Mendelian study to tissue
culture to molecular genetics. Molecular genetics is the study and manipula-
tion of DNA molecules that make up the genes that paved the way for the
advent of modern biotechnology as it applies to medicine and agriculture
(Persley, 2001) and which has gained much momentum since two decades
ago. In agricultural biotechnology, gene (s) is introduced to products, plants,
animals or microorganisms with novel traits (FAO, 2003). Modern science
has allowed the development of agricultural biotechnology which is made up
of various kinds of techniques and products and GMO is just one of them
(FAO, 2003). Agricultural biotechnology can bring about a wide range of
products that has input traits, output traits and medicinal traits as outlined in
Table 1.
Given these, the purpose of this paper is first to study the global agricultural
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Input traits
Plant engineering/breeding Crop transformation
Trait expression/protection technologies
Selective breeding technologies. e.g., genomic mapping/tracking
Fertility control and apomixis




Yield ennancement Plant biomass
Crop and pruduce yield/quantity, e.g., grain, fruit, fiber
Abiotic stress tolerance
Plant nutrition and water use
Output traits
Food, feed and nutrition Micronutrients, e.g., iron, vitamins
Protein composition and quality, e.g., amino acids yield/profiles
Vegetable oils/waxes, e.g., quality, stability
Cabohydrates, e.g., starch/gums yield and quality
Phytochemicals, e.g., isoflavones, antioxidants
Food quality, improved shelf life, reduced allergenicity/macotoxins.
Food processing Plants as expression/delivery systems for food enzymes, e.g., lactase, lipase
Enzymes for improved food processing and consistency, with
reduced waste, e.g., phytase, cellulase





Nutraceuticals and Natural products, nutraceuticals, medicinal phytochemicals
pharmaceuticals Therapeuticallyt bioactive molecules modified in planta. e.g., ex-
ploiting novelphytochemistry and/or processing
Plants as expression/delivery systems for therapeutics, e.g., edible
vaccines, plantibodies
Source: David McElroy, Sustaining Agri-biotechnology Through Lean Times, Nature Biotechnolo-
gy, Vol. 21, No.9, 2003, p. 997.
biotechnology industry and the issues at stake that divide the global com-
munity. We will then evaluate the attitudes, goals and interests of countries
in the North and South in regard to biotech crops. Then we will assess the
food safety in the food supply chain. The food safety measures and instru-
ments at the national and international context that are being implemented
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to pacify the anxieties of people with regard to the food they eat will be exa-
mined. Drawing lessons from the experiences and taking a proactive stance,
I will present a framework of measures developing countries in Asia can im-
plement before there is full blown adoption, commercialization and trade of
biotech food and to assure everyone that the food they eat are safe. It is
hoped that the results of this research could serve useful to policy makers
not only in Asia but also in other developing countries in the world.
Debates about Agricultural Biotechnology
The adoption and commercialization of biotech crops have remained a much-
debated issue worldwide. One camp states the potential risks to human
health and the environment that modern biotechnology poses. They argue
that consumers see no benefits but rather fear that they are faced with
potential risks to their health on the following grounds: risk of food allergens
when there is transfer of genes from common food that can cause allergies;
toxicity, carcinogenicity; food intolerance; use of gene marking for antibiotic
resistance, etc. (Persley, 2001, WTO, 2004). The fear that the genes
transferred (e.g. antibiotic resistance gene) may be transferred to the body,
which can be hazardous to the health as well as the risk on food safety of
genes of GM crops transferred to traditional crops in the wild, is there. The
potential risks to the environment likewise have been emphasized time and
again. Not only does gene transfer pose health risk to humans but to the en-
vironment as well when genes from GMOs cross over to crops of the same
species or to other species (e.g. weeds) referred to as gene escape. Genes
can also mutate and cause harm and native varieties can be lost threatening
biodiversity. Non-target species (e.g., birds and non harmful insects) can
become susceptible to the gene product (WTO, 2004). There is also the
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potential risk of creating a new kind of selection process with the introduc-
tion of GMOs in the ecosystem (Persley, 2001).
In the North, there are sentiments against the role of the originators of
GMOs, the giant seed/chemical MNCs who tend to monopolize the seed mar-
ket for GMO crops that could make the farmers highly dependent on them
(referred to as terminator technology) (WTO 2004) rather than use their
own seed stocks. This is where the issue of intellectual property rights
comes in for the seed and chemical MNCs like Monsanto, Dupont, DOW,
BASF, Syngenta and Bayer that have to spend substantial time and capital
to finance 85% of the global R&D worth $900M per year (Elroy, 2003). On
top of this, regulatory approvals of agricultural biotechnology products cost
$20-30 M in 2003, which only the large MNCs can afford to pay (Persley,
2001). Elroy (2003) mentioned that in agricultural biotechnology it takes 1-
5 years for trait generation; 1-2 years for trait optimization; 1-2 years for
proof of concept of model plant; 1-2 years for early event testing and de-
velopment; 5-8 years for field trial breeding and regulatory approval and 2-
3 years commercialization, in total, 11-22 years. Due to much consumer op-
position in the adoption and commercialization of GM crops in Europe,
Japan and other countries, there are fewer rewards for the companies' in-
vestments. Hence there is not much interest in channeling funds to agricul-
tural biotechnology. It is for these reasons that MNCs seek protection of
their intellectual property and patents for seeds, planting materials and tools
of genetic engineering (Fresno, 2001). These big companies cater only to
crops that can be grown in commercial scale such as corn, soybeans, canola
and cotton to be able to get a return on their massive investments. But the
strong anti-GMO movement in ED has negative impact on the industry lead-
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ing to a reduction in investments in agricultural biotechnology. Thus consoli-
dation and restructuring in the industry to conserve R&D expenses ensued.
While this is all happening in the West, countries in the East specially the
developing countries saw the potentials of transgenic crops and have been
increasing investments, notably, China, India and Brazil. Among Asian na-
tions, China that embarked on agribiotechnology way back in the 1980s had
the highest R&D expenditures in 2001, which amounted to U$115M, 63% of
the total R&D budget for developing countries of U$180 as presented in Ta-
ble 2 (Clive, 2004). China has approved 31 GM crops for commercializa-
tion, which include rice, wheat and corn. Public and private R&D invest-
ments in India have been substantial and in 2002 the government allowed the
field trials of GM mustard, soybean and corn with R&D funded by contribu-
tions from the private (U$10M) and public (U$15M) sectors. Another camp
argues that modern science has much to contribute to agriculture and food
security. They point out that agricultural biotechnology can lead to improved
productivity and is a substitute to the extensive use of agricultural chemicals
which is harmful to human health and environment, and in the long term will
result to sustainable agriculture. Output traits of crops can be changed that
offer product differentiation such as improved durability (shelf life) and
nutritional value (e.g. Vitamin A enriched rice) or soybean oil with low un-
saturated fat (Elroy, 2001). Looking at the economics of agribiotechnology
crops, the use of fewer pesticides translates to less cost to the farmer caus-
ing a ripple effect to the wholesaler, processor, retailer and the consumer.
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Table 2. Global R&D on Crop Biotechnology. 2001*











Source: Clive James, ISAAA, Global R&D Expenditures in Crop Biotechnology and
Future GM Crop Market, 2004 (http://www.Isaaa.org)
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Agricultural Biotechnology in Developing Countries
For the past decade, there has been a dramatic increase in the cultivation of
approved biotech crops, mostly crops grown large scale, in terms of acreage
from 1. 7M has. in 1996 to 81M has. in 2004 with the share of the developing
countries continuously on the rise as shown in Figure 1 (Clive, 2004). The
area grown to biotech crops in developing countries reached 27. 6M has.
which accounted for 34% of the total world area in 2004.
In 2003, only 2M farmers grew biotech crops but a year later this increased
to 8.15M farmers in 17 countries. More recently the adoption of agricultural
biotechnology (e.g. GMO crops) in terms of acreage in developing countries
is increasing at a rate three times more than that of the advanced countries.
Countries in Asia such as India, China, Indonesia and the Philippines are
preparing to commercialize GMOs. As a matter of fact, the percentage in-
crease (35%) in developing countries for 2003-04 is higher than in indus-














Trend of Global Area Planted to Biotech Crops, 1995-2004
Million Hectares (1996 to 2004)
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Increase of20%, 13.3 million hectares or 32.9 million acres between 2003 and 2004.
Source: Clive James, Global Status of Commercialized Biotech/GM Crops: 2004,
Executive Summary, ISAAA, p. 5.
tries that grow biotech crops are developing nations: Brazil, China, India,
Mexico, Argentina, Uruguay, Honduras, South Africa, Philippines, Romania
and Colombia. Of these three are in Asia: China, India and Philippines
(Figure 2).
Agricultural Biotechnology in the North and South: What is the
Difference?
From now on the adoption and commercialization of biotech crops will in-
crease in developing countries basically to meet their domestic food and feed
needs, and to provide export earnings (ISAAA, 2004) and many see biotech
to be the solution to the pressing problems of hunger, malnutrition and
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Source: Clive James, Global Status of Commercialized Biotech/GM Crops: 2004,
Executive Summary, ISAAA, p. 3.
poverty in many nations in the South. Most companies that spend much
money on R&D in GMO are from the industrialized county. In the US there
is widespread cultivation of GMO cotton, wheat, corn, soybean and canola.
These multinationals are the ones introducing the GMO products to other
developed countries and developing countries. Even GMO products are be-
coming global with the increase in their trade and investment. Hence in the
West there is strong leadership in the industry, which is economically moti-
vated.
In many developing countries GMOs are seen in light of it providing food
security, reducing poverty and malnutrition and promoting sustainability and
protecting the environment in the long run. The use of GMO seeds leads to
improved productivity to farmers, since the crops will be resistant to pests
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and diseases; the farmers will be using less pesticide and chemicals which
will be better for their health and the environment as well. Moreover,
through genetic engineering, more nutritious (e.g., golden rice), vitamin-en-
riched and higher quality of crops will be produced. Most of the R&D in
GMOs are done by biotech companies in DCs and their application really do
not suit the most urgent needs of the developing nations (Fresco, 2001).
Mostly what these countries grow are GMO soybean, maize and cotton and
not the much needed more nutritious, drought resistant, salinity tolerant,
etc. homegrown crops. Agricultural biotechnology in Asia, is basically done
and extended by public institutions and universities to address the urgent
need to improve the welfare of the marginal farmers in the countryside.
Biotechnology R&D, particularly GMOs are very costly which firms in de-
veloping countries do not have the capacity and the finances to do so. Hence
they have to rely on MNCs for transgenic crop input supplies. In case it is
developed in the LDC, R&D is usually publicly funded in collaboration with
universities and other research institutes and international agencies, and pri-
vate investment is minimal. The government is obligated to do this to serve
the farmers. But then the government should not brush aside the potential
health risks of the GMO to individuals and the environment that might be
over shadowed in its drive to meet the welfare and economic goals. In ad-
vanced and developing countries there are many new GMO products in the
pipeline and many more to be field tested and ready for commercial use and
will be in the increase in the coming years. In the previous section, we have
outlined the technology inherent risks of agricultural biotechnology. In addi-
tion to this Lehrer (2000) had presented the technology transcending risk
(e.g., more people suffering from poverty). Given this let us see the situa-
tion in many developing countries.
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In Asia for example, for the past two decades manufacturing has taken over
agriculture in terms of contribution to GDP although agriculture still
remains an important sector since a majority of the population who live in
the rural areas still depend on agriculture for their livelihood. Agricultural
biotechnology is seen to have great potentials in solving food and supply
security in Asia. Land is scarce in the Asian region that houses 70% of the
world population. The agricultural sector has to provide the food needs of an
expanding population projected to reach 8 billion by 2025, a majority of
whom live in Asia. Constrained by the limitations in the expansion of land
for cultivation in Asia, biotechnology can significantly increase production
and simultaneously improve food quality for sustainable land use. It can like-
wise reduce the use of chemicals and pesticides, and develop drought
resistant crops that can grow on rain-fed areas. Agricultural biotechnology
offers great potentials not only for increasing food and agricultural produc-
tion but also quality and nutritional improvement, alleviation of post-harvest
losses of subsistence farmers specially those in the marginal areas where it is
difficult to increase productivity. All in all this can lead to significant welfare
changes for the regions concerned, more income for the Asian farmers and
lift them from persistent poverty, malnourishment and food insecurity, often
the root causes of discontent and insurgency. While there is a need for inten-
sification of agricultural production, sustainable agriculture has to be
promoted, not only during technology generation and adoption, but also in
the training and education of farmers, extension officers, local community
and government officials so as to avoid the adverse impact of past ex-
periences. Poverty has been a push factor for rural-urban migration in seeks
of employment. This often leads to problems related to the urban poor. To
alleviate this problem then it is likewise important to provide livelihood to
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the rural agrarian population by uplifting them from subsistence agriculture
to agribusiness that can add more value to the agricultural produce. These
agricultural goods then can be geared for the domestic or export market.
Many developing countries have comparative advantages as far as agricul-
tural production is concerned which can be explored to become foreign ex-
change earners for the country. Agricultural biotechnology can be an im-
portant tool to accelerate development and improvement of the standard of
living in Asian countries, especially the developing nations of Asia who do
not wish to be left out of the innovation benefits of biotechnology nor be left
in a disadvantaged position vis a vis the industrialized countries. With
minimal private efforts directed toward agricultural biotechnology; public
sector endeavors in the R&D of biotech crops have the interest of the
producers utmost in mind more than the consumers. The government looks
after the producers welfare due to the deeper socio-economic and political
impact of doing otherwise.
The position the people take in the West may has different rationale and
justification as that in the developing countries as far as modern agricultural
biotechnology is concerned where the socio economic situation and problems
are far more pressing and urgent. With the adoption of agricultural biotech
crops farmers would stand to benefit from improved productivity and sus-
tainable farming; and the consumers will have access to cheaper and more
nutritious crops. In many developing countries where many people have low
income, the largest portion of their budget goes to food. But at this point it
has to be emphasized that although modern biotech crops can give these
benefits to farmers and consumers to meet their urgent needs, care has to be
taken that food safety specially in the developing areas be given the utmost
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importance. Many people in developing countries reside in the non-urban
area who have less capability and means to access to information about
GMOs. Food safety and health regulations both domestic and international
as well as practices should be strictly followed. Public awareness of the food
people eat and the potential risk has to be undertaken. Lack of education can
be a barrier to consumer knowledge about biotech foods and information dis-
semination about them is still not in place. Moreover labeling of products
with GMOs can be done in urban areas as well as in established retailers but
not in the public markets in the rural areas. Against this situation in the de-
veloping countries, the role of the public (national) sector is very important
proactively to make sure of the safety of food grown commercially.
Regulatory Requirements
To have economies of scale the GMO crops that are commercially grown and
traded like corn soybean, cotton, and canola are not what the developing
countries would really like to produce. For each of the transgenic crops,
government regulatory requirements mandate that the health, environment
and safety information be provided which cost U$10M each (FAO, 2004).
In many countries agricultural biotech researches are done by the public sec-
tor on crops that would answer the local food and feed needs as well as food
security as outlined below.
These crops that range from staples to vegetables and plantation crops (ex-
port crops) are traditional and domestic crops that are important for the lo-
cal people and the local economy. A study of Cohen (2005) of 15 developing
countries reveals that most of the R&D on GMOs done in developing coun-
tries are conducted by public institutions with public interest in mind. But
these GM crops usually remain in the pre-commercial stage due mainly to
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Table 3. Homegrown GM crops in the Pipeline, Asia.
Country Crops in the Pipeline
China Cabbage, chili, cotton, maize, melons, papaya,
potato, rice, soybean, tomato
India Cabbage, cauliflower, chickpea, citrus, eggplant,
mung bean, muskmelon, mustard/rapeseed, potato, rice, tomato
Indonesia Cacao, cassava, chili pepper, coffee, groundnut, maize, mung bean,
papaya, potato, rice, shallot, soybean, sugarcane, sweet potato
Malaysia Oil palm, papaya, rice
Pakistan Cotton, rice
Philippines Bananas, maize, mango, papaya, rice, tomato
Thailand Cotton, papaya, pepper, rice
Source: Joel Cohen, Nature Biotechnology, Poorer Nations Tum to Publicly Developed GM Crops.
Vol 23, No. L Jan 2005.
the costly regulatory requirements, foremost of which is biosafety. In Brazil
for instance cost of compliance per event (the incorporation of foreign DNA
to a living plant cell) is U$700, 000 for virus resistant papaya and U$4M for
herbicide resistant soybean while in Costa Rica it cost U$2. 5M for virus
resistant rice (Cohen, 2005). But then there is the issue of intellectual
property rights. Is it a public good that would free farmers of any patent
problem? R&D on GMOs can amount to U$30M and US$5-6M to meet
regulatory requirements. Hence these large capital requirements require
huge returns. Does the public sector have enough capacity, resource and
will to do agricultural biotechnology to serve the public need?
Food Supply Chain and Food Safety
The components of the supply chain consist of the following: input suppliers
(seed, agricultural chemicals), farmers, wholesalers, processors, the retail-
ers, and consumers. This is a chain of direct in-line functions and implies
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direct linkage among separate functions. It means that each function is de-
pendent upon the others and the overall chain cannot be stronger than its
weakest link. Hence the viability of the food chain rests upon the viability of
the other elements of the food chain. There are many participants in each
component of the supply chain and the supply chain participants vary in size,
level of technological sophistication, management capability and capital in-
tensiveness and ownership depending on the country where they operate. In-
put suppliers, mostly MNCs and their subsidiaries monopolize the seed mar-
ket (GMO crops), especially for the terminator seed in developing countries.
Farm production units are numerous and scattered of various sizes, struc-
tures and composition producing according to their comparative advantage
and specialization. Produce of widely dispersed farms goes through the
wholesalers to the processors and finally to the retailers. Who among these
value creation supply chain participants are the main beneficiaries of the
agricultural biotechnology (e.g. GMOs)? Who among them have to take
responsibility for food safety?
In the introduction of GMOs into the market, the consumers have to see the
benefits may it be price, quality, nutrition and of course, food safety, other-
wise they would not purchase. The consumers are the driving force behind
the entire food system (Neil, 2001). The consumer response can always be
positive or negative and the result will be felt in the whole food chain. As
mentioned earlier, the viability of food system depends on the viability of
each participant. The input suppliers (GMO seed firms), processors, and
retailers (and even the restaurants) have to meet the needs and preferences
of the consumers, one of which is safe food. Moreover, food chain par-
ticipants anticipate the consumer's response and adopt strategies according-
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ly. Nestle of Switzerland says they operate to please the needs of consumers.
Hence they sell GMO products where consumers buy them and do not sell
where consumers oppose it. Danome, a French company known for its bis-
cuits, yogurt and mineral water abides by the new rules and delivers what
the consumers prefer. Albert Heikin in the Netherlands stores only
10 products with GMO out of thousands of product lines it carries.
McDonalds decided to cut the use of meat raised with antibiotics since more
consumers are demanding safe food. The antibiotics administered to animals
might lead to antibiotics resistance to humans so that many people now
resort to organic grown products which are carried by 73% of food stores in
the US. In Japan, to increase consumer's value, all participants in the value
chain are taking every measure of product safety assurance. It has been a
concerted effort and responsibility between the value chain participants.
Food producers, processors as well as retailers are doing their utmost best:
retailers are keen on labeling, disclosure and traceability and the processors
try to monitor the raw materials/ingredients they use. One measure taken
by retailers is to obtain safety assurance certification in Japan (Japan
agricultural standard (JAS)) and oversee the products they will carry. Aeon
Co., a large retailer in Japan, sells beef with the JAS mark and provides all
the information about the beef, the date of birth, breed, slaughter date, the
medicines and feeds. Ito Yokaido Co., a major supermarket operator, puts a
seal in the vegetables they sell indicating the website consumers can log on
into. But agribusiness outsourcing has been on the rise in recent years. This
necessitates a stricter rule of conduct. Japan Tobacco now sells frozen
vegetables grown and processed in China. To allay fears of safety for food
coming from other countries, the company checks the vegetables they buy
from local suppliers for chemical residues and re-check them again before
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they are shipped to Japan. All product history can be checked in its website.
Ajinomoto on the other hand puts the production and processing of frozen
vegetables in China under its strict supervision. There are some cases where
the processors and retailers take responsibility as well in assuring that the
food they offer are safe. These could serve as examples to other supply
chain agents in developing countries although the infrastructures are differ-
ent.
In developing countries this supply chain is undeveloped and still in the de-
veloping stage. The industry is not as well-organized as that in the west
where countries have advanced and cutting edge technology and national
agricultural research system, well placed regulatory framework, intellectual
property laws and developed local input market so they can join the gene
revolution (FAO, 2004). The suppliers of GMO are a few MNCs which
control the seed market. A case in point is the transgenic cotton, Bt cotton
(trade name of Bollgard (r), developed by Monsanto, USA) which contains
the gene of bacillus thuringiensis that makes it resistant to caterpillar pests
and herbicide and insect resistant BT/HT cotton developed in 1997. It was
first cultivated in the US, Australia, Mexico in 1996 and since then have
been introduced in Argentina, China, Colombia, India, Indonesia and South
Africa with Monsanto providing planting materials. However there are
domestic companies in India and state-owned enterprises in China that have
commercialized the planting of cotton. But majority of the seeds of local
crops are developed in public institutions and distributed to small farmers
through the extension arms of the government. In developing countries the
agricultural biotech industry is still in the infant stage where much of the
R&D are done by public institutions to address more pressing needs such as
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poverty, malnutrition and food security. Price is still a determining factor in
the purchase decision of consumers in developing countries with regard to
food without much concern about the potential health risks. The food supply
chain and the regulatory framework in developing countries are still weak.
The pressing concern about transgenic food however is safety. Are they
harmful to the health? There is no scientific evidence that GMO foods are
harmful to the health according to the scientific community. But the con-
sumers will decide given all the information whether to buy GMO products
or not. This decision will then ripple back to the participants of the food
chain. Ordinary consumers are not much informed about GMOs in Asia and
for them price is still the determining factor for the purchase.
International Food Safety Regulations
Governments of various countries have regulatory policies, programs and
instruments that vary in degree, sophistication and extent. Hence parallel to
the national regulatory efforts are international agreements that would bind,
attune and govern transnational issues about agricultural biotechnology. In
this section we will examine the instruments of governance as far as food
safety is concerned. Domestic regulations need to be in harmony with inter-
national regulations. Developing countries then that are still trying to
strengthen their national regulations can be guided and bound by the inter-
national framework. With increasing commercialization and trade of GMOs




International Plant Protection Convention
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The Cartagena Biosafety Protocol was adapted in 2002. It is an internation-
al agreement related to GMOs (or living modified organism (LMO)) and in-
cludes setting of standards with regard to international movement, transit,
handling, packaging, identification and use of LMOs that can have harmful
effects on the conservation and sustainable use of biological diversity and
risk to human health (Fresco, 2001). The Codex Alimentarius was an
agreement reached in 2003 that sets the principles for evaluating food deri-
ved from transgenic crops and guidelines on food safety using GMOs. Stan-
dards for risk assessment and labeling are still under discussions (FAO,
2004). The WTO agreement on the Application of Sanitary and Phytosani-
tary Measures (SPS agreement) was adopted in 1994 and enforced in 1995.
The agreement stipulates that countries should retain their rights to ensure
that the food, animal, and plant products they import are safe. It states too
that countries should use international standards to create their require-
ments for sanitary and phytosanitary measures (FAO, 2004). The Interna-
tional Plant Protection Convention (IPPC) mandate is to prevent the spread
and introduction of plants, and plant product pests and to apply the necessa-
ry measures. This applies to GMOs. (Fresco, 2001). Many countries in de-
veloping countries in Asia do not have the instruments that relate to food
safety of GMOs. Some have food safety measures but none specifically for
GMOs although these measures are applied to GMOs as stop gap measures
(Glowka, 2003).
Imports of GMOs into ED, Japan and South Korea are strictly regulated. En-
try of GMOs into these markets especially ED, which has the strictest
instruments on GMOs has caused a lot of trade disputes. In the ED there is
mandatory labeling regulation for food and food ingredients with GMOs and
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a new traceability law has been put in place in 2003. GMO foods, known as
Frankenfoods, are not very popular and some ED countries continue to op-
pose approving new GM crop varieties. Many consumers shun the Franken
foods hence producers are pressed to suit the consumers wants. In 2003 to
appease the countries that oppose GM food, the new EU Parliament passed
new laws that required tracing and labeling of all products with at least 0.9
% GMO ingredients and should be labeled as GM products. This labeling in
stores started in April 2004. Labeling will also be required for animal feed
and all products containing highly refined soya or corn oil (Financial Times,
2004). Under the new regulation, farmers, manufacturers and distributors
need to collect and keep information regarding the origin, composition and
sale of GM products for five years (Daily Youmiuri, 2004). EU has the
strictest law on labeling in the world. But the traceability requirement does
not hold for meat, milk and eggs of animals fed with GMOs feeds. This
marked the end of EU's 6-year moratorium on new biotech food thus allow-
ing the GMO insect resistant corn developed by Swiss company Syngenta
into the EU market for human consumption. In 2003, the EU Commission
enacted rules for GMOs and now that the consumers are sufficiently in-
formed, they can decide if they buy the corn or not. Six years ago the EU
gave its consent to some GM crops but Europe remained divided. Hence the
moratorium was suggested due to the growing public fear of health and en-
vironment risks of GM crops. More investigation on the influence of GMO
on health and the environment has come up with no scientific evidence that
GMO are harmful but anti-GMO activists claim these can not be said with
certainty (Economist. 2004). Hence although the GMOs food may be
available in the market, and with the requirement labeling, there is no
guarantee that consumers will buy them.
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The US has been pro-GMO, being one of the biggest producers of GMO corn
and wheat. Prominent agribiotech companies such as DOW, Dupont, and
Monsanto are American multinationals. And the US government is putting
pressure on many countries to open their market to GMO products. In the U-
nited States, there is no specific regulation for GMOs. Rather GMOs are co-
vered by existing laws nor is there a mandatory risk assessment for GMOs
(Baumuller, 2003) There is a proposal to mandate companies to provide the
information on the safety of the GMOs food before marketing them via the
Premarket Notice Concerning Bioengineered Food (Baumuller2003). Un-
like in the ED where labeling is required, labeling of GM foods in the US is
voluntary as provided by the Voluntary Draft Guidelines of the Food and
Drug Administration. China since March 2002 has implemented instruments
on GMO safety evaluation, import and labeling. The Biosafety Regulation of
GMOs in Agriculture is a regulation to safeguard not only the environment
but also health from the research phase to the field trial and to production
processing and trade. Also GM soya, canola, tomatoes have to be labeled
(Greenpeace, 2003). In India government approval is needed for the im-
port of soya oil and maize. Japan on the other hand has zero tolerance for
GMO food. Consumer acceptance of GMO is important when the main con-
cern is food safety, quality and health risk. Safety assessment of all recom-
binant DNA (rDNA) organisms whose properties have been altered are con-
ducted and has to be approved by the Ministry of Agriculture, Fisheries and
Forestry. Just like Japan, Korea bans all forms of GMOs. There is mandato-
ry labeling of GM soybeans, corn, bean sprouts as of 2001, and potatoes in
2002 in Korea. As of 2003, the importation of GMOs for food and feeds and
processing into the Philippines needs a permit. Whereas in Thailand there
are moves to require labeling of soy and corn products. Thailand has to
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weigh the potential risks and rewards of GMOs since one of their main ex-
ports is agricultural products and their biggest markets include ED and
Japan where the consumers are very sensitive to GMO foods. Hence
Thailand is caught in a quagmire since it wants to be a regional biotechnolo-
gy hub in Asia.
Food Safety Measures
Some countries in Asia like India and the Philippines have national biosafety
committees which will be responsible for the policies and programs regard-
ing the use of biotechnology, both locally developed and imported biotech
products. The committees have to coordinate with the different institutions
in the country involved in biotechnolgoy R&D. Other countries have biosafe-
ty regulatory and food safety measures although some of these measures do
not contain regulation of GMOs. These biosafety and food safety instru-
ments have to be strengthened so as to command the trust of the par-
ticipants of the food supply chain, the consumers in particular. With the in-
creasing R&D, adoption and commercialization and trade of GMOs from
now on, Asian countries are still faced with many challenges offered by: 1.
Inadequate understanding of biosafety among the ordinary people; 2. Inade-
quate well-trained staff who can develop and implement the bio safety regu-
lations: 3. Lack of funding to do the risk assessment; 4. Lack of expertise
in the evaluation of risk in the field trials and commercial use of GMOs; 5.
Lack of facilities to conduct risk assessment and inadequate institutional
capacity. Against this background and given the government policies and
biosafety committees to assure food safety, the following steps can be under-
taken.
Agricultural Biotechnology: Implications on the
Food Supply Chain and Food Safety
Scientific assessment
109
Scientific risk assessment of GM crops based on established guidelines as
well as in abidance to the Codex principle and market monitoring should be
done. There has to be science-based biosafety assessment on a case-by-case
basis. Although no harmful effects of GMO for instance have been detected
there has to be non-stop evaluation and monitoring to be able to tract the
long terms effects. In many developing countries there has been a strength-
ening of regulatory mechanism to guarantee that consumers and the environ-
ment are protected from potential risks. There can be pre and post release
assessment on the possible impact on food safety to ensure that toxins are
not transferred or created nor allergens are not transferred from one species
to another (FAO, 2003). Efforts have to be exerted to direct more interna-
tional and local grants to food safety risk assessment and monitoring.
Labeling
Labeling may add costs to the firm that will be passed on to the consumer.
Due to budget constraints, or no other food alternative or a lack of
knowledge of the food labels consumers in developing countries may not al-
ways take notice of the food labels. Nevertheless, the public/consumers can
be provided all the information about GM ingredients in products and let
them make the rational choice.
Education and public awareness
Education of producers, processors, retailers and consumers alike of the
potential benefits and risks of biotech crops is important and let them make
informed decisions. This could be done using the extension arms of the na-
tional and local government in cooperation with community associations in
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the countryside as well as electronic and print media to disseminate informa-
tion.
Technical and institutional capacity building
In developing countries there is still the need for capacity building of local
researchers and scientists on the pre and post commercialization assessment
of the safety of biotech food crops as well as national and local government
officials who would be involved in the development, implementation and up-
dating of local food safety programs and regulations.
Regional cooperation
On the regional perspetive, nations in Asia should work together and coor-
dinate their efforts to make sure that the GMOs that are being developed are
safe before they are disseminated and commercialized given the fact that
these countries more or less grow similar crops and are faced with con-
straints such as human, financial and institutional capital. Information (data
base) sharing is very important as far as risk assessment and analysis are
concerned so that they can avoid duplication and save on the cost of risk as-
sessment, which is very costly given the financial constraints.
Conclusion
The adoption of GMO crops and transnational trade in agricultural crops are
expected to increase from now, in spite of the intensive debate that sur-
rounds it. The goals, focuses and attitudes towards biotech food (e.g.
GMOs) differ between the North and South because the needs and intensity
of the food needs for these countries are different. The need for safe food is
recognized by the industry, government and consumers and is a basic
Agricultural Biotechnology: Implications on the
Food Supply Chain and Food Safety 111
criterion for global trade. Although there are claims by the scientific com-
munity that transgenic crops pose no health hazard we need not be compla-
cent. It is of utmost importance that pre and post commercialization scientif-
ic based assessment of the potential risk of GMOs be done on a case to case
basis. Developing nations in Asia are starting to adopt GMOs introduced
from the industrialized countries and are in the pre-commercial release stage
of home grown crops, all in the hope to address urgent needs of poverty,
malnutrition and food security which are the root causes of more serious eco-
nomic, social and political dilemmas. Given this scenario, then there needs to
be a proactive approach so that before the full blown adoption and commer-
cialization of biotech crops, guidelines and measures have to be put in place
to assure the safety of the food people eat. This can be a taxing and long
term task since the food supply chain is still undeveloped unlike in more ad-
vanced countries where each supply chain participant takes on the respon-
sibility of food safety within the guidelines set by the national and interna-
tional regulations. Unlike in Europe, US and Japan, many developing na-
tions have no strict regulatory system on GMOs in place yet. Thus the na-
tional governments in developing countries need to put in place the domestic
regulatory procedures and institutions in harmony with the global guidelines
as set by the Codex alimentarius and the Cartagena Protocol which set the
international standards and hence harmonize the risk assessment systems
while many developing countries are still in the processes of framing up their
guidelines. It is important to enhance public awareness, education and train-
ing on biosafety of all supply chain agents. Traditional consumers make the
choice of food based on their income, tastes and preferences, and lifestyle as
well as the price of the product. Nowadays the purchase decision has
become more complicated taking into consideration issues of health, quality
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and food safety. Hence the preservation of consumer confidence has become
very important and has become a prime task of the industry, comprising of
the supply chain agents and the government. By supply agents we mean the
input suppliers, farm producers, processors, retailers, restaurants that are
engaged in value creation to satisfy the expectations of consumers which are
different in the advanced countries (North) and developing countries
(South). Moreover, labeling, capacity building and regional cooperation are
measures that can be undertaken at the domestic and international fronts.
Government regulations, taxes, etc. can be put in place to monitor the de-
velopment and use of biotechnology in all industries to protect the con-
sumers and at the same time giving them freedom of choice. We should sup-
port and build upon the achievements of agricultural biotechnology, which
can be used for the betterment of our society and environment if guided in
the proper direction. Biotechnology can be used as a tool and not as a foe.
FAG (2004) further cautions that agricultural biotechnology need not be a
replacement for traditional agricultural techniques but rather they should be
complementary, specially in times when agricultural biotechnology and
traditional breeding methods are unsuccessful. As what Tweeten, a well-
known agricultural economist said, science and technology Gn agriculture)
can be used as a solution to the problem rather than causing the problem.
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